Dr. Jennifer Rittenberry, M.D
NPI: 1699797688
Total Payments
$259,875
2024 Payments
$23.73
Companies
44
Transactions
2,011
Medicare Patients
1,265
Medicare Billing
$147,228
Payment Breakdown by Category
Other$202,563 (77.9%)
Food & Beverage$29,370 (11.3%)
Consulting$14,493 (5.6%)
Travel$13,168 (5.1%)
Education$280.91 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $202,563 | 180 | 77.9% |
| Food and Beverage | $29,370 | 1,760 | 11.3% |
| Consulting Fee | $14,493 | 6 | 5.6% |
| Travel and Lodging | $13,168 | 56 | 5.1% |
| Education | $280.91 | 9 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mannkind Corporation | $115,494 | 442 | $0 (2024) |
| Novo Nordisk Inc | $90,224 | 360 | $0 (2021) |
| Tandem Diabetes Care, Inc. | $24,822 | 122 | $0 (2020) |
| Valeritas, Inc. | $12,024 | 70 | $0 (2019) |
| DEXCOM, INC. | $2,615 | 77 | $0 (2021) |
| AbbVie Inc. | $2,219 | 77 | $0 (2021) |
| Insulet Corporation | $1,630 | 58 | $0 (2020) |
| Amgen Inc. | $961.30 | 56 | $0 (2020) |
| Lilly USA, LLC | $945.43 | 130 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $940.75 | 81 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.73 | 1 | Mannkind Corporation ($23.73) |
| 2023 | $20.77 | 1 | MannKind Corporation ($20.77) |
| 2021 | $17,668 | 77 | MannKind Corporation ($10,216) |
| 2020 | $39,646 | 215 | Novo Nordisk Inc ($15,969) |
| 2019 | $83,973 | 571 | Novo Nordisk Inc ($35,594) |
| 2018 | $75,302 | 560 | MannKind Corporation ($31,494) |
| 2017 | $43,243 | 586 | Mannkind Corporation ($25,830) |
All Payment Transactions
2,011 individual payment records from CMS Open Payments — Page 1 of 81
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: DIABETES MEDICINE | ||||||
| 03/02/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/17/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/18/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $56.63 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/07/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $105.93 | General |
| Category: Cardiovascular | ||||||
| 09/30/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/24/2021 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $32.68 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/05/2021 | MannKind Corporation | AFREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $354.16 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/05/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $33.15 | General |
| Category: Diabetes Care | ||||||
| 05/04/2021 | MannKind Corporation | AFREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/04/2021 | MannKind Corporation | AFREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/04/2021 | MannKind Corporation | AFREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $354.16 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/03/2021 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,210.00 | General |
| Category: Diabetes | ||||||
| 05/03/2021 | MannKind Corporation | AFREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $354.16 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/03/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $120.52 | General |
| Category: Diabetes | ||||||
| 04/30/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Diabetes | ||||||
| 04/30/2021 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: DIABETES MEDICINE | ||||||
| 04/30/2021 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $5.55 | General |
| Category: DIABETES MEDICINE | ||||||
| 04/30/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $1.20 | General |
| Category: Diabetes | ||||||
| 04/28/2021 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: DIABETES MEDICINE | ||||||
| 04/28/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/28/2021 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $4.39 | General |
| Category: DIABETES MEDICINE | ||||||
| 04/28/2021 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: DIABETES MEDICINE | ||||||
| 04/27/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $56.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/26/2021 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $2.39 | General |
| Category: DIABETES MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 8 | 399 | 1,395 | $64,915 | $34,644 |
| 2020 | 13 | 866 | 4,172 | $223,355 | $112,583 |
Total Patients
1,265
Total Services
5,567
Medicare Billing
$147,228
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 16 | 960 | $21,120 | $14,591 | 69.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 120 | 129 | $21,285 | $8,379 | 39.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 64 | 72 | $14,760 | $8,365 | 56.7% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 52 | 65 | $3,250 | $1,525 | 46.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 19 | 20 | $1,800 | $1,010 | 56.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 34 | 37 | $740.00 | $332.80 | 45.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 77 | 91 | $910.00 | $287.26 | 31.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 17 | 21 | $1,050 | $154.98 | 14.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 30 | 2,940 | $64,680 | $45,616 | 70.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 258 | 378 | $62,370 | $26,079 | 41.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 110 | 168 | $34,440 | $17,417 | 50.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 64 | 80 | $7,200 | $5,703 | 79.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 37 | 37 | $14,800 | $5,446 | 36.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 68 | 141 | $13,650 | $3,682 | 27.0% |
| 76536 | Ultrasound of head and neck | Office | 2020 | 37 | 40 | $11,600 | $3,133 | 27.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 14 | 14 | $4,550 | $1,689 | 37.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 19 | 21 | $1,260 | $923.88 | 73.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 33 | 74 | $3,700 | $793.22 | 21.4% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 61 | 82 | $1,640 | $781.50 | 47.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 13 | $1,625 | $725.97 | 44.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 123 | 184 | $1,840 | $594.57 | 32.3% |
About Dr. Jennifer Rittenberry, M.D
Dr. Jennifer Rittenberry, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Dublin, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699797688.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Rittenberry, M.D has received a total of $259,875 in payments from pharmaceutical and medical device companies, with $23.73 received in 2024. These payments were reported across 2,011 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($202,563).
As a Medicare-enrolled provider, Rittenberry has provided services to 1,265 Medicare beneficiaries, totaling 5,567 services with total Medicare billing of $147,228. Data is available for 2 years (2020–2021), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Dublin, OH
- Active Since 07/25/2006
- Last Updated 04/30/2021
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1699797688
Products in Payments
- AFREZZA (Drug) $115,494
- Ozempic (Drug) $51,907
- t-slim insulin pump (Device) $18,295
- V-GO (Device) $12,690
- Tresiba (Drug) $11,770
- RYBELSUS (Drug) $10,074
- t:slim X2 insulin pump (Device) $6,528
- Victoza (Drug) $5,661
- Omnipod (Device) $1,630
- Creon (Drug) $1,176
- Dexcom G5 Mobile CGM System (Device) $960.71
- INVOKANA (Drug) $893.59
- JARDIANCE (Drug) $788.65
- Dexcom CGM (Device) $714.88
- FARXIGA (Drug) $624.42
- Livalo (Drug) $565.54
- DEXCOM CGM (Device) $487.90
- UNITHROID (Drug) $428.41
- Vascepa (Drug) $426.60
- DEXCOM G6 CGM SYSTEM (Device) $413.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Dublin
Pallavy Reddy, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $38,816
Endocrinology, Diabetes & Metabolism $38,816
Dr. John Stafford, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1,364
Endocrinology, Diabetes & Metabolism $1,364
Deval Bhatt, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $416.46
Endocrinology, Diabetes & Metabolism $416.46
Taylor Cater, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $318.60
Endocrinology, Diabetes & Metabolism $318.60
Traci Tupper, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $244.56
Endocrinology, Diabetes & Metabolism $244.56
Dr. Aruna Chakravorty, M.d., Phd, M.D., PHD
Endocrinology, Diabetes & Metabolism — Payments: $175.79
Endocrinology, Diabetes & Metabolism $175.79